Fespixon Cream

DRUG4 trials

Sponsors

National Defense Medical Center, Taiwan, Taipei Medical University WanFang Hospital, Cathay General Hospital, Oneness Biotech Co., Ltd.

Conditions

Chronic Diabetic Foot UlcerDiabetic Foot Ulcer (DFU)Pressure Injury Stage 2Scar

Phase 4

Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery

CompletedNCT05271708

National Defense Medical Center, TaiwanScar

Start: 2022-01-05End: 2022-11-30Updated: 2022-12-28

Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound

TerminatedNCT05317442

Taipei Medical University WanFang HospitalPressure Injury Stage 2

Start: 2022-04-06End: 2024-04-19Updated: 2024-05-01

Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

CompletedNCT05338463

Cathay General HospitalChronic Diabetic Foot Ulcer

Start: 2021-12-01End: 2024-03-22Updated: 2024-04-03

Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

TerminatedNCT05438251

Oneness Biotech Co., Ltd.Diabetic Foot Ulcer (DFU)

Start: 2022-08-04End: 2024-04-03Updated: 2024-05-16